Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Durbin DSHEA Reform To Focus On Mandatory AERs, Labeling Accuracy

This article was originally published in The Tan Sheet

Executive Summary

Sen. Richard Durbin (D-Ill.) will push for mandatory adverse event reporting and stricter labeling standards for dietary supplements, as well as exclusion of certain products from the legal definition of supplements, in the 108th Congress

You may also be interested in...



Steroid Precursor Legislative Action Gains Momentum

"Pro-steroid" and "precursor steroid" products' proliferation in the dietary supplement market "raise[s] questions about whether additional federal action should be taken," according to the House Energy & Commerce Committee

Steroid Precursor Legislative Action Gains Momentum

"Pro-steroid" and "precursor steroid" products' proliferation in the dietary supplement market "raise[s] questions about whether additional federal action should be taken," according to the House Energy & Commerce Committee

Steroid Precursor Legislative Action Gains Momentum

"Pro-steroid" and "precursor steroid" products' proliferation in the dietary supplement market "raise[s] questions about whether additional federal action should be taken," according to the House Energy & Commerce Committee

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095024

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel